Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer
Clinical trial NCT05994339 · UNKNOWN
Trial details
- NCT number
- NCT05994339
- Sponsor
- Laibin People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-08-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.